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ABSTRACT
Nonsense-mediated mRNA decay (NMD) is a
molecular pathway of mRNA surveillance that
ensures rapid degradation of mRNAs containing
premature translation termination codons (PTCs) in
eukaryotes. NMD has been shown to also regulate
normal gene expression and thus emerged as one
of the key post-transcriptional mechanisms of gene
regulation. Recently, NMD efficiency has been
shown to vary between cell types and individuals
thus implicating NMD as a modulator of genetic
disease severity. We have now specifically analysed
the molecular mechanism of variable NMD effi-
ciency and first established an assay system for
the quantification of NMD efficiency, which is based
on carefully validated cellular NMD target tran-
scripts. In a HeLa cell model system, NMD efficiency
is shown to be remarkably variable and to represent
a stable characteristic of different strains. In one of
these strains, low NMD efficiency is shown to be
functionally related to the reduced abundance of the
exon junction component RNPS1. Furthermore,
restoration of functional RNPS1 expression, but
not of NMD-inactive mutant proteins, also restores
efficient NMD in this model. We conclude that
cellular concentrations of RNPS1 can modify NMD
efficiency and propose that cell type specific
co-factor availability represents a novel principle
that controls NMD.
INTRODUCTION
Nonsense mediated decay (NMD) is a surveillance path-
way by which cells recognize and limit the expression of
mRNAs containing premature stop codons (PTCs) and
thus reduce the expression of potentially harmful trun-
cated proteins (1–4). Originally, NMD was thought to
represent a control mechanism to limit the expression of
faulty transcripts with frameshift or nonsense mutations,
which originate from point mutations or from aberrant
splicing. The ﬁnding of NMD being involved in negative
feedback loops regulating normal gene expression fore-
shadowed a wider role of NMD as a basic post-
transcriptional cellular process (5–7). More recently,
microarray analyses of yeast (8,9), Drosophila (10) and
human cells (11–13) have revealed that NMD modulates
the levels of a large number of normal transcripts.
Furthermore, NMD has been suggested to vary in its
eﬃciency. In Saccharomyces cerevisiae, the degradation of
the pre-mRNA of CYH2 (an endogenous NMD target)
has been reported to vary in diﬀerent strains (14). In
humans, the expression of dystrophin and JARID1C
genes carrying identical nonsense mutations has been
reported to diﬀer and to modulate disease severity (15,16).
Moreover, tissue-speciﬁc diﬀerences of NMD eﬃciency
for nonsense-mutated collagen X have been suggested in a
patient with Schmid metaphyseal chondrodysplasia (17).
More recently, intertissue and interindividual variations in
NMD eﬃciency have been proposed in the study of two
fetuses diagnosed with Roberts syndrome and carrying a
homozygous frameshift mutation in the ESCO2 gene (18).
These observations led to the hypothesis that variations of
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variability of hereditary disorders (19,20). However, it
has so far been diﬃcult to quantify NMD eﬃciency.
Here, we have developed an assay system that estimates
diﬀerences of NMD eﬃciency based on an internally
controlled measurement of the expression of cellular
NMD targets. Applying this assay in a HeLa cell model
system we demonstrate variable NMD eﬃciency between
strains. Functionally, these diﬀerences are shown to be
caused by a deﬁciency of RNPS1, a key protein in at least
one of the known NMD pathways (12). We thus propose
that cell type speciﬁc co-factor availability represents a
novel principle that controls NMD.
MATERIALS AND METHODS
Cell culture, transfections, RNA isolation and analysis
HeLa cells were grown in DMEM supplemented with
10% fetal calf serum (FCS) and 1% penicillin/streptomy-
cin at 378C and 5% CO2. HeLa strain A has been used by
our laboratory for many years (21,22). Strain B (ACC 57)
was purchased at the German Repository of Cell lines
(DSMZ). Strain C was kindly provided by Dr Elisa
Izaurralde (EMBL, Heidelberg).
For plasmid and siRNA transfections, we used pre-
viously described methods (23). We isolated RNA
according to standard protocols with TRIzol reagent
(Invitrogen, CA, USA) and performed northern blot
analysis as described previously (23) using 2–3mg RNA
per lane. Target sequences of siRNAs for luciferase, UPF1
and UPF2 were described previously (23). For estimations
of mRNA half-life, actinomycinD (5mg/ml) was added to
the growth medium 48h after siRNA treatment and RNA
was collected every hour. Transcript abundance was
quantiﬁed by quantitative RT-PCR as in the other cases.
The half-life of the FOS transcript was used to monitor
eﬃcient inhibition of transcription.
Complementary RNA preparation andMicroarray hybridi-
zation and analysis
We assessed the integrity of total cytoplasmic RNA from
the cultured cells using a Agilent 2100 Bioanalyzer
(Agilent, Palo Alto, CA, USA). We performed prepara-
tion, processing and hybridization of labelled and
fragmented cRNA targets to Aﬀymetrix HG_U133A
GeneChips
TM according to the manufacturer’s protocols
(Aﬀymetrix Inc., Santa Clara, CA, USA). Oligonucleotide
arrays were scanned using a confocal laser scanner
(GeneArray
TM, Hewlett Packard, Palo Alto, CA, USA).
Statistical analysis ofmicroarray data
Three independent experiments with UPF1 siRNA or
Luciferase siRNA as a negative control were analysed. We
used the Aﬀymetrix GeneChip Suite 5.0 software (MAS
5.0) to calculate raw expression values for each of the
22283 probe sets on the U133A oligonucleotide array.
Signal intensities were calculated as average intensity
diﬀerence (AID) between perfect and mismatch probes.
Approximately 8800 probe sets continuously resulting in
absent calls were excluded from the analyses. Next, we
used GeneSpring 4.2.1 (Silicon Genetics, Redwood City,
CA, USA) for scaling, normalization and background
correction of all genes and arrays. We performed
Student’s t-test on normalized relative expression ratios
to identify signiﬁcant diﬀerentially expressed genes with a
minimum factor of diﬀerence of42-fold, within the 95%
conﬁdence interval (P50.05). Full data sets are available
in the Supplementary Data and on the Gene Expression
Omnibus (GEO) repository (GSE7009).
Quantitative Real-Time PCR (LightCycler)
We synthesized ﬁrst strand cDNA using MuMLV
RNaseH- Reverse Transcriptase (MBI Fermentas) accord-
ing to the manufacturer’s protocol using 4mg of RNA.
We carried out real-time PCR, using the LightCycler
system (Roche Diagnostics, Mannheim, Germany), as an
independent method to assess diﬀerences of gene expres-
sion and to validate the microarray expression data.
We performed expression analyses of selected genes with
single-stranded cDNA and gene-speciﬁc primers (primer
sequences are available on request). We used the FastStart
DNA Master SYBR Green kit (Roche Diagnostics) to
quantify the mRNA levels by measuring real-time ﬂuori-
metric intensity of SYBR green I incorporation. The
working concentrations of gene-speciﬁc primer, MgCl2,
enzyme and SYBR green as well as cycling parameters
were optimized according to the LightCycler protocol
(LightCycler Operator’s Manual, Version 3.5). For the
experiments done in exclusively in strain A cells, we used
the concentration of glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) to normalize all other genes tested from
identical cDNA samples. For the other experiments
also the ribosomal protein L32 (RPL32), hypoxanthine
phosphoribosyltransferase 1 (HPRT1) and core-binding
factor-beta subunit (CBFB) were included as standard
controls. The ratio of each analysed cDNA was determined
as the mean of 4 or 5 experiments. Melting curves of the
PCR products were performed for quality control. The
primer sequences of SC35 and GAPDH were described
previously(12).ForTBL2:gcagtcatttaccacatgc/tattgtttctgc
ttcttggat, for GADD45B: gagtgagactgactgcaagc/tcttatta
attcgcaaactgg, for NAT9: attgtgctggatgccgaga/acctagcgtg
gtcactccgta, for RPL32: ttgacaacagggttcgtag/ttcttggaggaa
acattgtg, for HPRT1: gaccagtcaacaggggacat/aacacttcgtgg
ggtccttttc and for CBFB: gcccatctttacatacaca/acttcaaattat
tactggctac.
Proteinisolation and immunoblot analysis
We prepared protein lysates with an isotonic lysis buﬀer as
described previously (23). For total extracts, the buﬀer
composition was 50mM Tris-HCl, pH 7.5, 150mM
NaCl,1mM EDTA,1% Triton X-100, 0.5%
Deoxycholate, 0.1% SDS,1  Complete protease inhibitor
(Roche). For the cytoplasmic fraction, the buﬀer was
50mM Tris-HCl, pH 7.2, 150mM NaCl, 0.5% (v/v)
NP-40, 0.1% Deoxycholate, 5mM Vanadyl-Ribosyl-
complex, 1mM Dithiothreitol, 0.5mM PMSF,
1  Complete protease inhibitor (Roche). We performed
Nucleic Acids Research, 2007, Vol. 35, No. 13 4543immunoblot analysis of protein samples using 10–15mgo f
total protein per lane as previously described (22).
Plasmid constructs
Plasmids for the expression of human b-globin WT and
NS39 (22), Y14, RNPS1 and RNPS169-121 (12) and the
loading control (23) were described previously.
RESULTS
Identification of bonafide cellular NMD targets
We aimed at developing an assay to estimate diﬀerences in
NMD eﬃciency based on the expression levels of
physiological NMD transcripts. To identify a panel of
endogenous direct NMD targets in human cells, HeLa
cells were treated with siRNA against the NMD-key
factor UPF1 (11,23,24) or Luciferase as a negative control.
UPF1-speciﬁc immunoblotting showed that this protein
was eﬃciently depleted to a level of 510% (Figure 1a).
Functionally, the inhibition of NMD was assessed by
monitoring the expression of (1) transfected nonsense
mutated b-globin mRNA (NS39) (Figure 1b), and (2) of
two known NMD-sensitive splice variants of SC35
[SFRS2, referred to as SC35A and B (5)] (Figure 1c
and d). In UPF1-depleted cells, both the b-globin NS39
reporter and the NMD sensitive SC35 isoforms were up-
modulated  5- and 15-fold, respectively, demonstrating
the eﬀective inhibition of NMD. RNA isolated from these
cells was analysed on Aﬀymetrix HG_U133A
GeneChips
TM. Of 22283 probe sets, representing
 14500 human genes, 9336 transcripts were expressed
at a level of more than two SDs above background and
were thus included in the analysis. A total of 265 probe
sets (2.8%) representing 227 genes were up-modulated
more than 2-fold, while 248 probe sets (2.6%) representing
202 genes were down-modulated more than 2-fold
(Supplementary Data, Tables 1 and 2). These data
indicate that a substantial number of genes are aﬀected
directly or indirectly by UPF1 activity.
In order to exclude transcripts that are aﬀected
by UPF1 depletion in an NMD-independent, non-
post-transcriptional fashion, we analysed mRNA and
pre-mRNA levels in a subset of 16 transcripts, chosen
because of their strong diﬀerential expression in the
microarray analyses. In several independent experiments
performed on UPF1-depleted HeLa cells that showed
eﬃciently inhibited NMD function (see Figure 1), pre-
mRNA and mRNA levels for the selected 16 transcripts
were quantiﬁed by RT-PCR (Figure 2). The microarray
data showing up-regulated mRNA abundance in UPF1-
depleted cells could be conﬁrmed by RT-PCR for all 16
transcripts. However, only in the case of TBL2 the
abundance of the pre-mRNA remained unchanged while
the abundance of the mRNA was up-modulated  8-fold.
In the case of NAT9, these diﬀerences were marginal. In
all other 14 RNAs, the abundance of the pre-mRNA and
the mRNA did not diﬀer signiﬁcantly, although in two
(KCNJ12, SEPW1) the pre-mRNA remained below the
threshold of 2-fold up-regulation, whereas the mRNA was
up-regulated to a level of42-fold. These data suggest that
Figure 1. UPF1 depletion up-modulates the abundance of transfected
and endogenous NMD reporters. (a) Immunoblot analysis of protein
lysates from HeLa cells transfected with siRNAs against luciferase as a
negative control or UPF1 using a UPF1-speciﬁc antibody. Serial
dilutions corresponding to 100, 50, 20 or 10% (lanes 1–4) of the initial
protein amount from luciferase-siRNA transfected cells were loaded to
assess the eﬃciency of the UPF1 siRNA knock-down (lane 5).
Reprobing with a tubulin-speciﬁc antibody was performed as a loading
control. (b) HeLa cells were transfected with siRNAs against luciferase
or UPF1. Thirty hours later, the cells were co-transfected with the
b-globin WT or NS39 reporter constructs and the control plasmid. The
indicated percentages correspond to the abundance levels of NS39
mRNAs compared to WT mRNAs after normalization for transfection
eﬃciency (ctrl.). The fold up-regulation represents the ratio of NS39
expression levels between UPF1 and Luc siRNA transfected cells.
Values and SEs were calculated from three independent experiments.
(c) Gene structure of SC35 (SFRS2). Intron 1 is constitutively spliced,
whereas exons 3 to 8 are subject to extensive alternative splicing. The
position of the ATG and the stop codon are indicated. The exon
composition of the two SC35 splice-variants, SC35A and SC35 B that
are subjected to NMD are shown below. The same pair of primers
(arrows) was used to simultaneously amplify both species.
(d) Quantitative RT-PCR analysis of the NMD-sensitive SC35
(SFRS2) variants in cells transfected with either UPF1 or luciferase
siRNAs using the primers depicted in (c) and normalized against
GAPDH expression. The mean and the SEs were calculated from ﬁve
independent experiments.
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Figure 2. Pre-mRNA and mRNA analysis distinguishes direct from
indirect NMD targets in UPF1-depleted cells. Quantitative RT-PCR
(LightCycler)for16UPF1-sensitivetranscriptsfromcellstransfectedwith
luciferase (negative control) or UPF1 siRNAs. The abundance of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used for nor-
malization.Thefoldup-modulationofpre-mRNAsandmRNAsbyUPF1
depletion (mean SE) were calculated from 5–7 independent GAPDH
normalized and LUC controlled experiments. Potential direct NMD
targets(arrows)weredeﬁnedasthosemRNAswithameanup-modulation
42-fold and with a mean pre-mRNA up-modulation52-fold.
4544 Nucleic Acids Research, 2007, Vol. 35, No. 13most of these mRNAs are likely up-modulated transcrip-
tionally and do not represent bona ﬁde NMD targets. By
implication, these data also suggest that a substantial
fraction, likely most of the almost 230 transcripts that are
up-modulated by UPF1 depletion in our microarray data
are indirect NMD targets.
Transcripts that are targeted by NMD are expected to
be stabilized by an inhibition of this pathway. We thus
analysed the decay rates of the KCNJ12, NAT9, SEPW1
and TBL2 mRNAs. We also included the GADD45B
transcript, which has previously been suggested to
represent an endogenous NMD target by in silico analysis
(25) and is experimentally shown to be up-modulated by
UPF1 depletion here (see below). Actinomycin D was
added to cells pre-treated with siRNA against UPF1 or
Luciferase. The short-lived FOS transcript was used as a
positive control to assess the block of transcription
(Figure 3a). Prolonged half-lives in UPF1-depleted cells
Figure 3. UPF1 depletion prolongs the half-lives of endogenous NMD targets. Decay rates of endogenous transcripts were measured in HeLa cells
that were transfected with Upf1 siRNA (solid line) or Luciferase siRNA (dashed line) as control. 48 hours later, the cells were treated with
actinomycin D (5mg/ml). Samples were taken every hour. mRNA levels were determined by RT-PCR quantiﬁcation. The results represent the mean
and standard deviation of three independent experiments. (a) The positive control FOS mRNA is stable in the absence of actinomycin D ( act.D)
but it decays rapidly following a block of transcription (+act.D). (b–f) mRNA decay of the selected transcripts.
Nucleic Acids Research, 2007, Vol. 35, No. 13 4545were detected for GADD45B, TBL2 and NAT9 conﬁrming
that UPF1 depletion increases the abundance of these
transcripts by reducing degradation (Figure 3b–d). It is
interesting to note that the degradation curve of the
GADD45B transcript appears to be biphasic while those of
the TBL2 and NAT9 transcripts appear to be monophasic.
A biphasic decay curve for NMD substrates has been
described previously (11,26,27) and can potentially be
attributed to degradation of the nonsense-mutated mRNA
during the ﬁrst round of translation. Those mRNAs that
escape degradation at that point are thought to be
unaﬀected thereafter by NMD (28). The stability of
SEPW1 and KCNJ12 did not show any eﬀect on UPF1
depletion (Figure 3e–f). Because of this and because of the
only marginal diﬀerence between pre-mRNA and mRNA
levels (Figure 2), we excluded these transcripts from
further analysis.
The role of NMD in directly modulating the abundance
of the TBL2, NAT9 and GADD45B transcripts was
further analysed by depleting UPF2, which interacts
with UPF1 in the NMD pathway (29,30). The eﬃcient
depletion of UPF2 to  10% was conﬁrmed by immuno-
blotting (Figure 4a) and, as a functional control, we
assessed the abundance of SC35(A) and SC35(B) isoforms
(referred to in the subsequent discussion as SC35). The
degree of up-modulation in UPF1-depleted and UPF2-
depleted cells was not signiﬁcantly diﬀerent for all four
analysed transcripts (Figure 4b). Taken together, these
results indicate that SC35, TBL2, NAT9 and GADD45B
are bona ﬁde NMD targets that depend on both UPF1 and
UPF2. Analysis of the structure of these transcripts using
sequence databases show that SC35 (A and B), TBL2 and
GADD45B possess a termination codon located more
than 55 bases from the last exon–exon junction, while
NAT9 contains an upstream open reading frame (uORF)
(Supplementary Figure 1). These structural features are
typical for cellular NMD targets (11,31), which may
explain the sensitivity of these endogenous mRNAs to
cellular NMD activity.
Different HeLa strains display remarkable variations
in NMD efficiency
Unpublished observations in our laboratory have pre-
viously suggested that diﬀerent strains of HeLa cells may
diﬀer in their NMD capacity. We have now used these
HeLa strains as a model system to quantify subtle
diﬀerences in NMD eﬃciency and to gain mechanistic
insight into this variability.
The panel of ﬁve validated cellular NMD target
transcripts (SC35 A+B, TBL2, NAT9 and GADD45B)
was used to systematically analyse the NMD eﬃciency
of three diﬀerent HeLa cell strains (referred to as A, B
and C). To avoid a potential bias of quantiﬁcation against
a single housekeeping gene, we selected four diﬀerent
transcripts (HPRT1, CBFB, GAPDH and RPL32) for
normalisation purposes (32,33). This group of control
transcripts was selected because (1) they showed 510%
variability in all of our microarray experiments (data not
shown); (2) they were expressed at diﬀerent steady-state
levels and (3) they belong to diﬀerent metabolic pathways
and are thus unlikely to be co-regulated. The comparison
of the degree of up-modulation following UPF1 depletion
showed similar results for all transcripts that were used for
normalisation (Supplementary Figure 2), which indicated
that all of these housekeeping genes can be used as
standards.
Quantiﬁcation of the ﬁve endogenous NMD targets
(SC35 A+B combined, GADD45B, NAT9 and TBL2)
against the four standards in these strains gave reprodu-
cible results in four independent experiments (Figure 5a).
All the transcripts were  2- to 3-fold signiﬁcantly more
abundant in strains B and C in comparison with strain A.
Strain C showed a trend towards lower mean expression
levels for the NMD targets than strain B, although these
diﬀerences were not statistically signiﬁcant. When the data
from the individual NMD targets were combined, the
same diﬀerences existed, which indicates the similar
behaviour for all the tested mRNAs and suggests a
stronger NMD capacity in cells of strain A (Figure 5b).
To validate our analysis, we estimated NMD eﬃciency
by a direct comparison of the down-modulation of
transfected, nonsense mutated b-globin (NS39) reporter
in four independent experiments (Figure 5c and d). The
down-modulation of the NS39 reporter diﬀered repro-
ducibly and signiﬁcantly between strains. In strain A
NMD eﬃciency was  2.5-fold stronger than in the strains
B and C, while strain C tended to be  1.5-fold stronger
than B. Thus, the quantiﬁcation of NMD eﬃciency by
Figure 4. UPF1 and UPF2 depletion cause similar degrees of
up-modulation of cellular NMD substrates. (a) Immunoblot analysis
of protein lysates from HeLa cells transfected with siRNAs against
luciferase as a negative control or UPF2 using a UPF2-speciﬁc
antibody. Serial dilutions corresponding to 100, 50, 20 or 10% (lanes
1–4) of the initial protein amount from luciferase-siRNA transfected
cells were loaded to assess the eﬃciency of the UPF2 siRNA depletion
(lane 5). Reprobing with a tubulin-speciﬁc antibody was performed as a
loading control. (b) Quantitative RT-PCR analysis of SC35 NMD-
sensitive variants, TBL2, GADD45B and NAT9 in cells transfected
with UPF1 or UPF2 siRNAs. The UPF1 and UPF2 siRNA treatments
were controlled by luciferase siRNA and normalised against GAPDH.
Mean and SEs were calculated from three independent experiments.
4546 Nucleic Acids Research, 2007, Vol. 35, No. 13analysis of cellular NMD target transcripts was conﬁrmed
by the independent analysis of the NS39 reporter.
These data demonstrate that diﬀerences of NMD
eﬃciency between human cell lines can be estimated by
measuring the abundance of transfected NMD-sensitive
reporters and by analysing the abundance of a carefully
validated panel of cellular NMD target transcripts.
RNPS1 abundance modulates NMD efficiency
Subsequently, we aimed at gaining insight into the
mechanism of variable NMD eﬃciency in these HeLa
strains. As a starting point, we analysed the abundance of
the key NMD proteins UPF1, UPF2 and UPF3b and of
the functionally critical exon junction complex compo-
nents Y14, Magoh and RNPS1 by immunoblotting in
both, total and cytoplasmic lysates (Figure 6a). The
abundance of the UPF proteins, Y14 and Magoh did not
diﬀer between the three strains. In contrast, RNPS1 is
shown to be less abundant in cells of strain B (Figure 6a).
To estimate this diﬀerence semi-quantitatively, we
compared the abundance of RNPS1 in lysates of cells of
strain B relative to dilutions of similar lysates of cells of
strain A and C. These results indicate that RNPS1 is
 50% less abundant in the cytoplasmic fraction in cells of
strain B (Figure 6b, left panel). In total lysates, the
abundance of RNPS1 in strain B is  30% of that in
strains A or C (Figure 6b, right panel).
We next functionally analysed if RNPS1 might be the
limiting factor for NMD in these cells and over-expressed
functional RNPS1 (12) in cells that were transfected with
b-globin reporter genes. We conﬁrmed that the transfec-
tion of pCI-NEO-Flag has no eﬀect on the abundance of
endogenous RNPS1 in any strain (Figure 7a, lower
western blot) and that the pCI-NEO-RNPS1 is expressed
at similar levels in the all three cell lines (Figure 7a, upper
western blot). Increasing amounts of RNPS1 decreased
the steady-state levels of the b-globin NS39 reporter up to
4-fold in cells of strain B but had no eﬀect in cells of
strains A and C (Figure 7a). This eﬀect is speciﬁc for
RNPS1, because over-expression of RNPS169-121
Figure 5. The abundance of cellular NMD targets reﬂects the variability of NMD eﬃciency in HeLa cell strains. (a) Quantiﬁcation of ﬁve
endogenous NMD transcripts (SC35 (A+B), GADD45B, NAT9 and TBL2) by real-time PCR in untransfected HeLa cells from three strains (A, B
and C). The values plotted represent the mean plus SD of the quantiﬁcation obtained using each of the four non-NMD targets for normalization in
four independent experiments. For each NMD transcript, the expression levels are relative to the abundance of the transcript in strain A cells in one
experiment arbitrarily set as 100. Signiﬁcant diﬀerences (P50.05) are indicated with a star. (b) Means and SDs of the RNA abundance were pooled
for the ﬁve NMD reporters (as shown in a). Signiﬁcant diﬀerences (P50.05) are indicated with a star. (c) Representative northern blot of RNA from
the three strains of HeLa cells that were transfected with b-globin WT or b-globin NS39. The quantiﬁcation reﬂects the data from the individual
experiment shown. (d) Quantiﬁcation of the NS39/WT ratio for the northern blots analysis. The bar diagram expresses the mean and SD for three
independent experiments.
Nucleic Acids Research, 2007, Vol. 35, No. 13 4547(a truncated version of RNPS1 known to be non-
functional in NMD (12)) does not aﬀect the down-
modulation of the NS39 reporter (Figure 7b).
Furthermore, the over-expression of Y14—a critical EJC
component for NMD function (23)—does not augment
NMD eﬃciency in this strain of HeLa cells (Figure 7c).
Based on the diﬀerences of RNPS1 abundance, the
reconstitution of NMD eﬃciency by over-expression of
a functional protein but not of a non-functional mutant
and ﬁnally the lack of an eﬀect of over-expressing another
critical NMD protein, we conclude that the abundance of
RNPS1 is limiting for NMD eﬃciency in HeLa strain B.
DISCUSSION
NMD has recently emerged as one of the critical post-
transcriptional processes that regulate gene expression by
targeting transcripts with truncated reading frames (9).
While the phenomenon of variable NMD eﬃciency has
been observed by many groups studying NMD (15–18,34),
we document here that NMD eﬃciency can be system-
atically analysed by quantifying bona ﬁde cellular NMD
targets. Such cellular NMD targets have previously been
thought to represent  1–10% of the total transcriptome
of human cells and yeast (9,11). However, our simulta-
neous analysis of pre-mRNA and mRNA abundance and
of mRNA stability of selected transcripts (Figures 2 and 3)
suggests that only a minority of UPF1-dependent
transcripts are up-modulated directly by an inactivation
of NMD. This apparently transcriptional eﬀect of UPF1
depletion may be caused by inﬂuencing the expression of
transcription factors either in an NMD-dependent fashion
or in a fashion that is related to the non-NMD functions
of UPF1 (35,36). This would indirectly aﬀect the synthesis
and the pre-mRNA abundance of target genes.
Alternatively, the UPF1 depletion may stimulate the
transcription of the up-modulated genes directly.
The ﬁve cellular NMD target mRNAs that were
analysed (SC35A, SC35B and the identiﬁed TBL2,
GADD45B and NAT9) here were also shown to be
UPF2-sensitive (Figure 4) and to contain structural
features (alternative splicing isoforms with premature
stop codons and uORFs) (Supplementary Figure 1) that
explain their NMD sensitivity. Interestingly, the quanti-
ﬁcation of this small set of carefully validated cellular
NMD targets reﬂected subtle diﬀerences of NMD
eﬃciency in diﬀerent strains of the same cell line thus
demonstrating that NMD eﬃciency can be measured
semi-quantitatively. Such measurements may help to
analyse NMD eﬃciency in more complex systems such
as in tissues or even in entire organisms. However, the
heterogeneity of the composition of such material will
Figure 6. The low abundance of RNPS1 correlates with low NMD eﬃciency in one HeLa strain. (a) Representative western blots of cytoplasmic
(cyto) and total lysates following staining with speciﬁc antibodies against UPF proteins, Y14, Magoh and RNPS1 in HeLa strains A,B and C.
Reprobing with a tubulin-speciﬁc antibody was performed as a loading control. (b) Serial dilutions corresponding to 100, 75, 50 or 20% of the initial
protein amount from cells of strain A and C were loaded to estimate the quantitative diﬀerences of RNPS1 abundance in cytoplasmic (cyto) or whole
lysates of HeLa cells strain B.
4548 Nucleic Acids Research, 2007, Vol. 35, No. 13Figure 7. RNPS1 enhances NMD eﬃciency in one HeLa strain. (a) Upper panel: representative northern blot of RNA from the three strains of
HeLa cells that were transfected with b-globin WT (W) or b-globin NS39 (N) and 0, 0.5 or 1mg of pCI-NEO-FlagRNPS1. The quantiﬁcation refers
to mean values (Mean) and standard deviation (SD) of three independent experiments. Lower panel: western blots of lysates from transfected HeLa
cells used in these experiments. The same extracts were run in two gels. After blotting, the upper membrane was probed using anti-ﬂag antibody and
the lower one was probed using anti-RNPS1 antibody. Both membranes were reprobed with anti-tubulin antibody to control the load. (b) Left:
representative northern blot of RNA from strain B cells that were transfected with b-globin WT(W) or b-globin NS39 (N) and 0, 0.5 or 1mg of pCI-
NEO-FlagRNPS1 or pCI-NEO-FlagRNPS169-121 as a negative control. The quantiﬁcation refers to mean values (Mean) and SD of three
independent experiments. Right: western blot of transfected strain B HeLa cells. An anti-ﬂag antibody was used to validate the expression of ﬂag-
RNPS169-121. As a further control, an extract of cells transfected with the full-length RNPS1 was also loaded. (c) Left: idem b) but transfecting
pCI-NEO-FlagY14 as a negative control. Right: western blot for the transfected strain B HeLa cells. An anti-ﬂag antibody was used to verify the
expression of ﬂag-Y14. The blot was reprobed with anti-tubulin to control the load.have to be controlled as a likely confounding factor of
such measurements.
NMD variability has previously been studied system-
atically only in yeast (14). The analysis of the yeast NMD
substrate CYH2 pre-mRNA in strain crosses suggested
that the variable eﬃciency of NMD is pleiotropic in this
organism. Although we cannot discard a multi-gene eﬀect
to also be important in human cells, the ﬁndings reported
here document that the abundance and functional
availability of a single NMD co-factor can be limiting
for NMD eﬃciency.
NMD is thought to require the interaction of the exon
junction complex (EJC) with the SURF complex that is
recruited to the ribosome at the site of translation
termination (30). The EJC is recruited to the RNA by
the spliceosome and is remodelled during nucleo-
cytoplasmic export (37). Structural analyses have shown
that the EJC is anchored to the RNA by a core that
consists of the proteins eIF4AIII and MNL51 (BTZ) and
the Y14/Magoh heterodimer (38,39). At the periphery of
the complex, a number of other proteins are thought to
establish the interaction of the EJC with other protein
networks and diﬀerent cellular functions (40,41). The
protein RNPS1 is one of these peripheral EJC proteins
that have previously been shown to activate the NMD
pathway following tethering to a NMD competent
position of the mRNA (23,42) and to be an important
component of one of two pathways implicated in NMD
(12). Interestingly, the data reported here now functionally
link the reduced abundance of this protein in one of the
cell lines to low NMD eﬃciency, thus for the ﬁrst time
implicating the natural abundance of an EJC protein to
the eﬃciency of NMD.
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Supplementary Data are available at NAR Online.
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